Loading clinical trials...
Loading clinical trials...
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Conditions
Interventions
Dexpramipexole
Locations
80
United States
Barrow Neurological Institute - St. Joseph's Hospital
Phoenix, Arizona, United States
University of California at San Francisco - Fresno
Fresno, California, United States
University of California, Irvine
Orange, California, United States
University of California, Davis
Sacramento, California, United States
California Pacific Medical Center
San Francisco, California, United States
Hospital for Special Care
New Britain, Connecticut, United States
Start Date
June 1, 2012
Primary Completion Date
February 1, 2013
Completion Date
February 1, 2013
Last Updated
May 3, 2022
NCT05204017
NCT07322003
NCT07414212
NCT07401121
NCT05104710
NCT03233646
Lead Sponsor
Knopp Biosciences
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions